Citius Pharmaceuticals is trading at $0.60, down 5.9% (-5.85%) amid broader risk-off trading, with no major company-specific announcement identified for August 20, 2026.
- Broader risk-off trading is pressuring equities as the Nasdaq and Dow decline more than 0.5%.
- Rising Treasury yields and geopolitical tensions are weighing on risk-sensitive assets.
- The August 14 earnings release reported revenue growth but continued losses and funding risks.